Publication: Involvement of uridine-nucleotide-stimulated P2Y receptors in neuronal growth and function
dc.contributor.author | Cansev, Mehmet | |
dc.contributor.buuauthor | CANSEV, MEHMET | |
dc.contributor.department | Tıp Fakültesi | |
dc.contributor.department | Farmakoloji ve Klinik Farmakoloji Ana Bilim Dalı | |
dc.contributor.orcid | 0000-0003-2918-5064 | |
dc.contributor.scopusid | 8872816100 | |
dc.date.accessioned | 2025-05-13T14:01:15Z | |
dc.date.issued | 2007-12-01 | |
dc.description.abstract | The uridine nucleotides UTP, UDP and UDP-sugars produce a variety of effects by activating specific G protein-coupled P2Y receptors, i.e., the P2Y2, P2Y4, P2Y6 and P2Y14 variants. Except for P2Y14 which has recently been defined, stimulation of P2Y receptors by UTP and/or UDP augments proliferation of adult multipotent neural stem cells; stimulates dopaminergic differentiation in human mesencephalic neural stem cells; and enhances neurite outgrowth in nerve growth factor-differentiated PC12 cells and cultured DRG neurons. UTP and/or UDP have been shown to affect neuronal function by depolarizing neurons from cultured amphibian sympathetic ganglia; increasing firing rates of neurons; enhancing presynaptic glutamate release and promoting long-term potentiation; and by stimulating noradrenaline release from cultured sympathetic neurons. Furthermore, by activating P2Y receptors, UTP and/or UDP exhibit neuroprotective effects via induction of microglial convergence and reactive astrogliosis; protection from serum starvation-induced apoptosis; and stimulation of α-secretase-dependent APP processing and sAPPα release. Antagonism of uridine- nucleotide-stimulated P2Y receptors or the second messengers they generate, or degradation of extracellular uridine nucleotides, can block the effects mediated by these receptors. These observations suggest that uridine-nucleotide-stimulated P2Y receptors may constitute possible therapeutic targets for diseases affecting neuronal survival or function. © 2007 Bentham Science Publishers Ltd. | |
dc.identifier.doi | 10.2174/187152407783220814 | |
dc.identifier.endpage | 229 | |
dc.identifier.issn | 1871-5249 | |
dc.identifier.issue | 4 | |
dc.identifier.scopus | 2-s2.0-37349007255 | |
dc.identifier.startpage | 223 | |
dc.identifier.uri | https://hdl.handle.net/11452/52708 | |
dc.identifier.volume | 7 | |
dc.indexed.scopus | Scopus | |
dc.language.iso | en | |
dc.relation.journal | Central Nervous System Agents in Medicinal Chemistry | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | UTP | |
dc.subject | Uridine | |
dc.subject | UDP | |
dc.subject | Survival | |
dc.subject | P2Y receptors | |
dc.subject | Neuronal function | |
dc.subject | Neurite outgrowth | |
dc.subject.scopus | Adenosine Triphosphate; Purinergic P2X7 Receptor; Macrophage | |
dc.title | Involvement of uridine-nucleotide-stimulated P2Y receptors in neuronal growth and function | |
dc.type | Review | |
dspace.entity.type | Publication | |
local.contributor.department | Tıp Fakültesi/Farmakoloji ve Klinik Farmakoloji Ana Bilim Dalı | |
relation.isAuthorOfPublication | 162b5961-162a-4862-89cd-97b30e2a2552 | |
relation.isAuthorOfPublication.latestForDiscovery | 162b5961-162a-4862-89cd-97b30e2a2552 |